Molecular insights into vascular aging. by Foote, Kirsty & Bennett, Martin
 
 





Aging of the vasculature is the leading risk factor for 
cardiovascular and cerebrovascular disease [1]. As such, 
strategies that delay vascular aging could minimize the 
risk of developing life-threatening vascular complica-
tions, enhance healthspan and prolong lifespan. How-
ever, such preventative and therapeutic approaches 
require identification of the pathophysiological changes 
underlying vascular aging, and the associated molecular 
mechanisms responsible.  
The healthy artery comprises endothelial cells (ECs), 
vascular smooth muscle cells (VSMCs) and the extra-
cellular matrix (ECM), all of which are susceptible to 
damage or disruption during aging [2]. The intima is 
composed of ECs, their basement membrane, and (in 
humans) occasional VSMCs. ECs line the lumen, act as 
a selective permeability barrier and anticoagulant sur-
face, and EC function helps control vascular tone. 
VSMCs form the bulk of the media and are primarily 
responsible for contraction and relaxation of the vessel. 
VSMCs also undergo proliferation, migration and de-
differentiation during vascular remodeling in injury or 
disease. The ECM is composed of structural proteins 
such as collagens and elastin that tether VSMCs 
together, provides structural support, and regulates the 
mechanical function of the vessel. Aging is associated 
with changes in both cellular components and the ECM. 
For example, aging induces EC dysfunction, reducing 
barrier integrity, promoting inflammation, and reducing 
the capacity of the vessel to vasodilate. VSMCs de-
differentiate from a contractile to a synthetic phenotype, 
where they become pro-migratory and proliferative, and 
can undergo apoptosis and senescence. Aging is 
associated with increased deposition of collagen and 
breakages in the elastic laminae. The overall effects of 
aging lead to increased arterial stiffness and inflam-
mation, thicker walls and lumen dilation, and a 
diminished ability to contract and relax. 
Rapid advances in geroscience have identified a 
‘Molecular Signature’ for the aged vessel that 
represents distinct underlying intracellular and extra-
cellular molecular processes (Figure 1). Intracellular 
events involve: oxidative stress, mitochondrial dys-
function, cellular senescence, DNA damage, epigenetic 
changes, telomere shortening, loss of proteostasis and 
an impaired resilience to stressful stimuli. Extracellular 
events include inflammatory cell infiltration, and largely 
involve   the  ECM,   including   alterations  in   collagen/ 








elastin content and post-synthetic modifications to 
collagen such as enhanced cross-linking.  
Although all of these processes are associated with 
vascular aging, it is unclear whether they are a cause or 
consequence of aging, how they are inter-related, and 
whether targeting one or more is sufficient to prevent or 
delay vascular aging. For example, we recently reported 
that mitochondrial function progressively deteriorates 
with aging of mouse arteries, associated with reduced 
mitochondrial DNA copy number (mtCN) and expres-
sion of enzymes that regulate mitochondrial DNA 
synthesis; we showed that increasing mtCN enhanced 
mitochondrial function and delayed the onset of 
multiple structural and functional parameters of vascu-
lar aging [3]. Although this demonstrates that genetic 
augmentation of mitochondrial function delays vascular 
aging, the mechanisms underlying mito-chondrial 
dysfunction and failure of the nuclear genome to 
compensate for reduced mitochondrial function and 
increase mtCN are not known. Reduced mtCN was 
associated with up-regulation of Twinkle helicase and 
transcription factor A, mitochondrial (TFAM), two 
major nuclear-encoded regulators of mtCN, and other 
nuclear-encoded proteins involved in mitochondrial 
function including peroxisome proliferator-activated 
receptor gamma coactivator 1-alpha (PGC1α) and com-
plex II of the electron transport chain. However, the 
failure of this compensatory communicative response 
between the two cellular genomes to restore mtCN 
levels with age raises the possibility that the inability to 
repair the aging deficit in mtCN may be irreversible 
beyond a certain point.  
In contrast, the ability of enhanced mitochondrial 
function since birth (as in our genetically altered mice) 
to delay vascular decline suggests that preventative and 
early intervention are key to delay vascular aging. 
Indeed, several studies have demonstrated beneficial 
effects of long-standing lifestyle changes such as caloric 
restriction (CR) and exercise, and compounds that 
mimic these processes. For example, β-hydroxybuty-
rate, a ketone released naturally during CR,  enhances 
cell division and protects against DNA damage and 
cellular senescence in ECs and VSMCs in older fasted 
mice via the Oct4-mediated LaminB1 pathway [4]. 
Similarly, the nicotinamide adenine dinucleotide (NAD+) 
booster nicotinamide mononucleotide (NMN) promoted 
angiogenesis and recapitulated  the benefits  of  exercise 





































via sirtuin 1-mediated inhibition of Notch sig-nalling in 
aged exercised mice [5]. 
 
Vascular stiffness is a major link between normal 
vascular aging and development of vascular com-
plications. Although the marked changes in ECM 
content and structure in aging influence vascular 
mechanical properties directly, aging also affects cell-
ECM interactions, and the stiffness of VSMCs them-
selves. For example, VSMCs can take on a stiffness 
phenotype [6] dependent on their differentiation and the 
local molecular environment.  Although the precise 
links between VSMC stiffness and altered contractility 
are not fully understood, VSMC stiffness appears to be 
regulated through cell-cell or cell-ECM interconnec-
tivity through cell surface receptors, which also control 
a host of signalling pathways that regulate VSMC 
proliferation and differentiation [2]. 
In summary, identification of the distinct molecular 
pathways involved in vascular aging provides great 
potential for therapeutics. Research efforts should  focus 
on disentangling the complex interactions between the 
molecular processes involved,  and testing the feasibility 
































that can limit the effects of oxidative stress, mito-
chondrial dysfunction, cellular senescence, and DNA 
damage. Arterial stiffness and central blood pressure 
(cBP) are excellent predictors of age-related complica-
tions [7] and can identify individuals at high risk 
allowing targeting of treatments. Rejuvenating the 
vascular wall may supplement lifestyle modifications 
such as exercise and CR, with agents that allow these 
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Figure 1. Model implicating the intracellular and extracellular molecular mechanisms involved
in  vascular  aging.  The  inter‐relationships  between  the  processes  remain  unclear  and  are  depicted  by
arrows  highlighting  possible  links.  (1)  Reactive  oxygen  species  (ROS)  can  damage  the mitochondria  and
mitochondrial DNA, which can further exacerbate mitochondrial dysfunction, and (2) can also damage the
nuclear genome (yellow stars); (3) Inter‐communication  is evident between the mitochondrial and nuclear
genomes  but  remains  complex.  Epigenetic modifications  are  also  involved  in  altering  the  nuclear  DNA
(green circles), and the chromosomal telomeres become shortened. Protein homeostasis  is disrupted, and
overall cellular resilience to molecular stressors (red arrows) is impaired. ROS, reactive oxygen species. 
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